Different TH2-TH1 balance in Vβ8 and Vβ6 subsets of splenocytes in NOD females in the early phase of diabetogenesis

Diabetes and Metabolism

Volumn 23, Issue 5, 1997, Pages 386-394

  Atlan Gepner, C ^a,c   Hermitte, L ^a   Janand Delenne, B ^a   Naquet, P ^b   Vialettes, B ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Autoimmune disease; Cytokines; Diabetes mellitus; Non obese diabetic mouse; T cell receptor

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; RAT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; DIABETES MELLITUS, TYPE 1; FEMALE; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED NOD; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 0030856210     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Candeias S, Katz J, Benoist C, Mathis D, Haskins K. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc Natl Acad Sci USA, 1991, 88, 6167-6170.
2. Nakano N, Kikutani H, Nishimoto H, Kishimoto T. T cell receptor Vβ gene usage of islet b cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med, 1991, 173, 1091-1097.
3. O'Reilly LA, Hutchings PR, Cracker PR et al. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol, 1991, 21, 1171-1180.
4. Waters SH, O'Neil JJ, Melican DT, Appel MC. Multiple TCR Vβ usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes, 1992, 41, 308-312.
5. Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell, 1993, 74, 1089-1100.
6. Sarukhan A, Gombert J-M, Olivi M, Bach J-F, Carnaud C, Garchon H-J. Anchored polymerase chain reaction-based analysis of the Vβ repertoire in the non-obese diabetic (NOD) mouse. Eur J Immunol, 1994, 24, 1750-1756.
7. Akhtar I, Gold JP, Pan LY et al. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med, 1995, 182, 87-97.
8. Bacelj A, Charlton B, Mandel TE. Prevention of cyclophophamide-induced diabetes by anti-Vβ8 T lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes, 1989, 38, 1492-1495.
9. Zipris D, Crow AR, Delovitch TL. Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes, 1991, 40, 429-435.
10. Maeda T, Sumida T, Kurasawa K et al. T-lymphocyte-repertoire of infiltrating T lymphocytes into NOD mouse pancreas. Diabetes, 1991, 40, 1580-1585.
11. Edouard P, Thivolet C, Bedossa P et al. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice. EurJ Immunol, 1993, 23, 727-733.
12. Conrad B, Weidmann E, Trucco G et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature, 1994, 371, 351-355.
13. Wegmann DR, Norbury-Glaser M, Daniel D. Insulin-specific T cells are predominant component of islet infiltrates in pre-diabetic NOD mice. EurJ Immunol, 1994, 24, 1853-1857.
14. Katz JD, Benoist C, Mathis D. T Helper cell subsets in insulin-dependent diabetes. Science, 1995, 268, 1185-1188.
15. Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG. Monoclonal T cells identified in early NOD islet infiltrates. Immunity, 1996, 4, 189-194.
16. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice : relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD. NON thyla donors. Diabetes, 1993, 42, 44-55.
17. Scott P. Selective differentiation of CD4+ T-helper cell subsets. Curr Opin Immunol, 1993, 5, 391-397.
18. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes, 1994, 43, 613-621.
19. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol, 1995, 25, 1056-1062.
20. Healey D, Ozegbe P, Arden SD, Chandler P, Hutton JC, Cooke A. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest, 1995, 95, 2979-2985.
21. Shimara A, Charlton B, Taylor-Edwards C, Fathman CG. β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes, 1996, 45, 1063-1067.
22. Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in Nonobese Diabetic Mice. J Exp Med, 1993, 178, 87-99.
23. b mice. J Exp Med, 1992, 175, 453-460.
24. Emilie D, Peuchmar M, Barad M et al. Visualizing interleukin-2 gene expression at the single cell level. Eur J Immunol, 1989, 19, 1619-1624.
25. lowCD4+ CD8+ thymocyte subset through an LFA-1- dependent adhesion-de-adhesion mechanism. Int Immunol, 1990, 2, 1021-1032.
26. Coffman B. Surface antigen expression and immunoglobulin rearrangement during pre-B-cell development. Immunol Rev, 1982, 69, 5-23.
27. Acha-Orbea H, Zinkernagel RM, Hengartner H. Cytotoxic T cell clone specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. J Immunol, 1985, 15, 31-36.
28. Staerz U, Rammensee HG, Benedetto J, Bevan M. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T-cell antigen receptor. J Immunol, 1985, 134, 3994-4000.
29. Li JH, Ohara J, Watson C, Tsang W, Paul WE. Derivation of a T-cell line that is highly responsive to IL-4 and 1L-2 (CT4.R) and of an 1L-2 hyporesponsive mutant of that line (CT4.S). J Immunol, 1989, 142, 800-804.
30. Moreau JL, Nabholz M, Diamanstein T, Malek T, Shevach E, Theze J. Monoclonal antibodies identify three epitopes clusters on the mouse p55 subunit of the IL-2R : relationship to IL-2 binding site. Eur J Immunol, 1987, 17, 929-935.
31. Smith KA, Savata MS, Oroszlan S. Production and characterization of monoclonal antibodies to human IL-2: strategy and tactics. J Immunol, 1983, 131, 1808-1815.
32. Beverly B, Kang SM, Lenardo MJ, Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol, 1992, 4, 661-667.
33. Serreze DV, Leiter EH. Defective activation of T suppressor cell function in non-obese diabetic mice. Potential relation to cytokine deficiencies. J Immunol, 1988, 140, 3801-3807.
34. Hatamori N, Yokono K, Nagata M, Shii K, Baba S. Impaired mitogen-induced expression of high-affinity interleukin 2 preceptors on spleen cells from NOD/Shi/Kbe mice. Diabetes, 1990, 39, 1070-1078.
35. Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J Immunol, 1991, 146, 3763-3771.
36. Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 1986, 35, 855-860.
37. Van der Pouw-Kraan T, De Jong R, Aarden L. Development of human ThI and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur J Immunol, 1993, 23, 1-5.
38. Bacelj A, Charlton B, Koulmanda M, Mandel TE. The role of Vβ8 cells in disease recurrence in isografts in diabetes in NOD mice. Transp Proc, 1990, 22, 2167-2168.
39. Berschick P, Fehsel K, Weltzien HU, Kolb H. Molecular analysis of the T-cell receptor Vβ5 and Vβ8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice. J Autoimmun, 1993, 6, 405-422.
40. Campbell IL, Kay TWH, Oxbrow L, Harrison LC. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest, 1991, 87, 739-742.
41. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB. Insulin-dependent diabetes in the NOD mouse model II. b-cell destruction in autoimmune diabetes is a Th2 and not a ThI mediated event. Autoimmunity, 1993, 15, 113-122.
42. Kaufman DL, Clare-Salzer M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 1993, 366, 69-72.
43. Shehadeh NN, LaRosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun, 1993, 6, 291-300.
44. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature, 1993, 366, 72-75.
45. Rothe H, Faust A, Schade U et al. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of indusible nitric oxide synthase and Interferon- gamma, but not interleukin-4. Diabetologia, 1994, 37, 1154-1158.
46. Muir A, Peck A, Clare-Salzer M et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest, 1995, 95, 628-634.
47. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RE INF-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol, 1995, 154, 4874-4882.
48. Luppi P, Trucco M. Superantigens in insulin-dependent diabetes mellitus. Springer Semin Immunopathol, 1996, 17, 333-362.
49. Radons J, Burkant V, Kolb H. MHC Class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice. Diabetes, 1997, 46, 379-385.